Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Taxotere (Docetaxel) Products Liability Litigation
Case Number:
2:16-md-02740
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
-
June 02, 2020
Sanofi Boots Some Plaintiffs From Chemo Hair Loss MDL
A Louisiana federal judge has ruled that cancer patients who started taking the chemo drug Taxotere before a certain date in 2006 can't sue Sanofi-Aventis US LLC under Louisiana law over claims of permanent hair loss, as evidence in a first bellwether trial firmly established that date as a cutoff.
-
January 24, 2020
Clock Has Run Out For Hair-Loss Patients In Chemo MDL
A Louisiana federal judge has refused to revive suits of two women who claim drugmaker Sanofi-Aventis didn't inform them that their chemo drug could cause permanent hair loss, saying there was no error in finding that their cases were filed years too late under Louisiana law.
-
October 28, 2019
Woman Wants New Trial In Sanofi Chemo Drug Bellwether
A woman who claims a chemotherapy drug made by Sanofi SA caused her to lose her hair permanently is asking a Louisiana federal court for a new trial after a jury sided against her, saying Sanofi's expert witness should not have been allowed to testify in the bellwether trial.
-
September 27, 2019
Sanofi Beats First Bellwether In Chemo Drug Hair Loss MDL
Sanofi was cleared of liability Thursday in the first bellwether trial in multidistrict litigation against drugmakers over claims that the chemotherapy drug Taxotere causes patients to lose their hair permanently.
-
September 04, 2019
Former FDA Head Can Testify In Sanofi Hair Loss Trial
Former Food and Drug Administration Commissioner Dr. David A. Kessler can testify at an upcoming multidistrict litigation bellwether trial that Sanofi should have warned patients the chemotherapy drug Taxotere can cause permanent hair loss, after a Louisiana federal judge rejected Sanofi's bid to bar him from the trial.
-
August 16, 2019
Chemo MDL Patients Shred Sanofi Bid To Delay Bellwether
Plaintiffs pursuing multidistrict litigation against several drug companies over their alleged failure to warn cancer patients of the "devastating" permanent hair loss caused by the chemotherapy drug Taxotere have heaped criticism on defendant Sanofi's attempt to delay a first bellwether trial scheduled to start in weeks.